ALS drug will be pulled from Canada, U.S. markets after failed trial

by Pelican Press
82 views 1 minutes read



ALS drug will be pulled from Canada, U.S. markets after failed trial


Amylyx Pharmaceuticals will withdraw its ALS drug – its only product in the market – from the U.S. and Canada after the treatment failed in a key late-stage trial.





Source link

#ALS #drug #pulled #Canada #U.S #markets #failed #trial

You may also like